Parallel Industries Inc. (EAPH)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2015	FY 2014
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2015	Dec 31, 2014
Net Income	-0.19	-0.32	-0.17	-0.6	-0.36
Stock-Based Compensation	-	-	-	0.3	-
Other Operating Activities	-0.27	0.43	0.16	0.04	0.63
Change in Accounts Payable	0.26	0.38	0	-	-0.15
Change in Other Net Operating Assets	0.01	0.02	-0	0.03	-0.32
Operating Cash Flow	-0.19	0.51	-0.01	-0.23	-0.2
Sale (Purchase) of Real Estate	-0.02	-0.02	-	-	-
Other Investing Activities	-	-	-	-0.46	-
Investing Cash Flow	-0.02	-0.02	-	-0.46	-
Short-Term Debt Issued	0	0	-	-	-
Long-Term Debt Issued	-	-	-	-	0.02
Total Debt Issued	0	0	-	-	0.02
Long-Term Debt Repaid	-	-	-	-	-0.1
Net Debt Issued (Repaid)	0	0	-	-	-0.08
Issuance of Common Stock	-	-	-	-	0.7
Financing Cash Flow	0	0	-	-	0.61
Foreign Exchange Rate Adjustments	-	-	-	0	0.09
Miscellaneous Cash Flow Adjustments	0.47	-	0.16	-	-
Net Cash Flow	0.26	0.49	0.16	-0.68	0.51
Levered Free Cash Flow	-1.17	0.26	-	-0.31	-0.7
Unlevered Free Cash Flow	-1.17	0.26	-	-0.31	-0.7
Change in Net Working Capital	1.06	-0.46	-	0.22	0.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.